Share price · GSK
Loading chart…
Prices are end-of-day (EOD), delayed by 24 hours · Adjusted for stock splits · Data via Databento
Unusual price moves
See what was announced around each unusual move
Research flags the days this stock moved far more than its sector fund, lists the news, filings and earnings dated around each one, and shows how much of its unusual movement fell on each asset's announcements.
Assets
(59 total)
| Target & Modality | |||
|---|---|---|---|
| Approved | BCMAAntibody–drug conjugate | Multiple Myeloma | |
| Approved | BAFF / BLyS (B-lymphocyte stimulator) · BAFF (BLyS)Monoclonal antibody | Systemic Lupus Erythematosus | |
Daprodustat(Jesduvroq) | Approved | HIF prolyl hydroxylase (HIF-PH1/2/3)Small molecule | Chronic Kidney Disease |
| Approved | IL-5Monoclonal antibody | Chronic Obstructive Pulmonary DiseaseAsthma | |
Epoprostenol(Flolan) | Approved | IP receptor (prostacyclin pathway)Small molecule | Hypertension |
Ezogabine(Potiga) | Approved | Kv7 potassium channelSmall molecule | Epilepsy |
| Approved | Glucocorticoid receptorSmall molecule | Asthma | |
| Approved | Glucocorticoid receptor + Muscarinic M3 receptor (ICS/LAMA combination) | Asthma | |
fluticasone furoate/umeclidinium/vilanterol(Trelegy Ellipta) | Approved | Muscarinic acetylcholine receptor (M3) · Beta-2 adrenergic receptor · Glucocorticoid receptor · Glucocorticoid receptor / Beta-2 adrenergic receptor / Muscarinic M3 receptor (ICS/LABA/LAMA triple combination)Small molecule | Chronic Obstructive Pulmonary DiseaseAsthma |
| Approved | Beta-2 adrenergic receptor · Glucocorticoid receptor · Glucocorticoid receptor / Beta-2 adrenergic receptorSmall molecule | Asthma | |
| Approved | Glucocorticoid receptorSmall molecule | Asthma | |
| Approved | Glucocorticoid receptor · Beta-2 adrenergic receptor · Glucocorticoid receptor / Beta-2 adrenergic receptorCombination | Asthma | |
GW815SF(Advair HFA) | Approved | Glucocorticoid receptor / Beta-2 adrenergic receptorSmall molecule | Asthma |
| Approved | — | Chronic Hepatitis B | |
| Approved | Voltage-gated sodium channelSmall molecule | Epilepsy |
Upcoming events
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.
Insider transactions
Unlock insider transactions
Research includes SEC Form 4 insider transactions: filed buys, sells, awards and exercises linked to the underlying filings.
Institutional holders
Unlock institutional holders
Research includes quarterly SEC 13F institutional ownership: top holders, aggregate positions and quarter-over-quarter context.